Pre-eclampsia medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
! Serum [[Magnesium]] Concentration (mg/dL) !! Effect | ! Serum | ||
[[Magnesium]] | |||
Concentration (mg/dL) !! Effect | |||
|- | |- | ||
|5–9 || Therapeutic range | |5–9 || Therapeutic range |
Revision as of 12:12, 16 October 2020
Pre-eclampsia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pre-eclampsia medical therapy On the Web |
American Roentgen Ray Society Images of Pre-eclampsia medical therapy |
Risk calculators and risk factors for Pre-eclampsia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ogheneochuko Ajari, MB.BS, MS [3]
Overview
- The aim of therapy is starting treatment in blood pressure≥ 140/90 mmHg in office or clinic and blood pressure ≥ 135/85 mmHg at home and reaching the target systolic blood pressure 110-140 mmHg and diastolic blood pressure less than 85 mmHg regardless the type of hypertension in pregnancy.
Treatment
Medical Therapy
- The mainstay of therapy for hypertension in preeclampsia is oral methyldopa, labetalol, oxprenolol, and nifedipine, and second or third line agents include hydralazine and prazosin.
- The mainstay of therapy for preeclampsia, who have proteinuria with severe hypertension or hypertension with neurologic signs and symptoms, is magnesium sulfate (MgSO4) for convulsion prophylaxis.
- Urgent therapy for severe hypertension( blood pressure >160/110) is oral nifedipine or intravenous labetalol or hydralazine or oral labetalol.[1]
Serum
Magnesium Concentration (mg/dL) !! Effect | |
---|---|
5–9 | Therapeutic range |
>9 | Loss of patellar reflexes |
> 12 | Respiratory paralysis |
> 30 | Cardiac arrest |
References
- ↑ . doi:10.1161/HYP.0000000000000065Hypertension. Check
|doi=
value (help). Missing or empty|title=
(help)